Literature DB >> 19069294

Update on progress controlling yellow fever in Africa, 2004-2008.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19069294

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  5 in total

1.  Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.

Authors:  Rebecca M Casey; Jennifer B Harris; Steve Ahuka-Mundeke; Meredith G Dixon; Gabriel M Kizito; Pierre M Nsele; Grace Umutesi; Janeen Laven; Olga Kosoy; Gilson Paluku; Abdou S Gueye; Terri B Hyde; Raimi Ewetola; Guylain K M Sheria; Jean-Jacques Muyembe-Tamfum; J Erin Staples
Journal:  N Engl J Med       Date:  2018-02-14       Impact factor: 91.245

2.  Design and Testing of Novel Lethal Ovitrap to Reduce Populations of Aedes Mosquitoes: Community-Based Participatory Research between Industry, Academia and Communities in Peru and Thailand.

Authors:  Valerie A Paz-Soldan; Josh Yukich; Amara Soonthorndhada; Maziel Giron; Charles S Apperson; Loganathan Ponnusamy; Coby Schal; Amy C Morrison; Joseph Keating; Dawn M Wesson
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

3.  Single shot of 17D vaccine may not confer life-long protection against yellow fever.

Authors:  Pedro Fc Vasconcelos
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11-27       Impact factor: 2.743

4.  Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.

Authors:  Emily S Jentes; Pauline Han; Mark D Gershman; Sowmya R Rao; Regina C LaRocque; J Erin Staples; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

5.  Yellow fever risk assessment in the Central African Republic.

Authors:  J Erin Staples; Mawlouth Diallo; Kristen B Janusz; Casimir Manengu; Rosamund F Lewis; William Perea; Sergio Yactayo; Amadou A Sall
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-06-19       Impact factor: 2.184
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.